Description
Emerging Trends in Cancer Research provides a comprehensive and up-to-date exploration of the latest advancements in cancer therapeutics, diagnostics, and intellectual property landscapes. Each chapter delves into the specific aspects of different cancers, offering insights into drug resistance mutations, biomarker trends, preclinical model updates, and clinical pipeline developments. The book also addresses the importance of diagnostics and the evolving landscape of intellectual property in cancer treatment. Sections analyze cancer drug resistance mutations, biomarker trends, and diagnostics across various cancers, including intestinal, cardiac, brain, and blood cancers.Readers will find coverage of clinical pipeline developments, intellectual property landscapes, and advancements in cancer therapeutics, diagnostics, and global drug delivery trends. This book is an invaluable resource for oncology, biomedical engineering, and pharmaceutical professionals, offering insights into the latest cancer research trends. It includes real-world case studies, practical applications, and discussions on regulatory and ethical considerations, making it essential for both seasoned researchers and graduate students.- Provides comprehensive, up-to-date insights into the latest advancements in cancer therapeutics, diagnostics, and intellectual property landscapes, covering a wide range of cancers (intestinal, cardiac, brain, and blood cancers)- Delivers detailed analyses of drug resistance mutations, biomarker trends, preclinical model updates, and clinical pipeline developments- Includes real-world case studies and practical applications, along with discussions on regulatory and ethical considerations
Table of Contents
1. Mapping Cancer Drug Resistance Mutations and Mechanisms2. Kidney-Urinary Bladder Cancer—Biomarkers Trends3. Importance of Diagnostics in Cardiac Cancer4. Brain Cancer—Preclinical Model Updates5. What's New in Liver Cancer Clinical Pipeline6. Lung Cancer: IP Landscape7. Colorectal Cancer Clinical Updates8. Breast Cancer IP Landscape9. Prostate Cancer Drugs in Clinical Trials10. Global Trends and Intellectual Property Landscape Focusing on Drug Delivery for Oral Cancer Treatment11. Sodium-Linolenic Channels in Cancer Diagnostics12. Oral Cancer Therapeutics13. Oral Cancer Microenvironments14. mRNA Trends in Cancer Therapeutics15. Blood Cancer Therapeutics16. Colorectal Diagnostics
